212 related articles for article (PubMed ID: 24570268)
1. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.
Jones J; Wang H; Karanam B; Theodore S; Dean-Colomb W; Welch DR; Grizzle W; Yates C
Clin Exp Metastasis; 2014 Jun; 31(5):497-510. PubMed ID: 24570268
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.
Vermeulen JF; van de Ven RA; Ercan C; van der Groep P; van der Wall E; Bult P; Christgen M; Lehmann U; Daniel J; van Diest PJ; Derksen PW
PLoS One; 2012; 7(5):e37864. PubMed ID: 22662240
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.
Jones J; Wang H; Zhou J; Hardy S; Turner T; Austin D; He Q; Wells A; Grizzle WE; Yates C
Am J Pathol; 2012 Nov; 181(5):1836-46. PubMed ID: 22974583
[TBL] [Abstract][Full Text] [Related]
4. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression.
Jones J; Mukherjee A; Karanam B; Davis M; Jaynes J; Reams RR; Dean-Colomb W; Yates C
Cancer Lett; 2016 Oct; 380(2):513-522. PubMed ID: 27424525
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Parshad R; Ralhan R
BMC Cancer; 2009 Sep; 9():325. PubMed ID: 19751508
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt.
ElMoneim HM; Zaghloul NM
Clinics (Sao Paulo); 2011; 66(10):1765-71. PubMed ID: 22012049
[TBL] [Abstract][Full Text] [Related]
7. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.
Chao YL; Shepard CR; Wells A
Mol Cancer; 2010 Jul; 9():179. PubMed ID: 20609236
[TBL] [Abstract][Full Text] [Related]
8. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
9. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
[TBL] [Abstract][Full Text] [Related]
10. Nuclear location of tumor suppressor protein maspin inhibits proliferation of breast cancer cells without affecting proliferation of normal epithelial cells.
Machowska M; Wachowicz K; Sopel M; Rzepecki R
BMC Cancer; 2014 Feb; 14():142. PubMed ID: 24581141
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma.
Gamallo C; Moreno-Bueno G; Sarrió D; Calero F; Hardisson D; Palacios J
Mod Pathol; 2001 Jul; 14(7):650-4. PubMed ID: 11454996
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract][Full Text] [Related]
14. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
15. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
16. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
18. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
20. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?
Montserrat N; Gallardo A; Escuin D; Catasus L; Prat J; Gutiérrez-Avignó FJ; Peiró G; Barnadas A; Lerma E
Hum Pathol; 2011 Jan; 42(1):103-10. PubMed ID: 20970163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
